Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 1/10/25 → 1/10/27 |
Funding
- Rho Incorporated: $20,824.00
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinson's Disease
- Slevin, John (PI)